Miwako Kobayashi Selected Research

23-valent pneumococcal capsular polysaccharide vaccine

2/2021	Decline in Receipt of Vaccines by Medicare Beneficiaries During the COVID-19 Pandemic - United States, 2020.
1/2021	Cost-effectiveness of implementing 13-valent pneumococcal conjugate vaccine for U.S. adults aged 19 years and older with underlying conditions.
11/2020	Cost-effectiveness of continuing pneumococcal conjugate vaccination at age 65 in the context of indirect effects from the childhood immunization program.
11/2019	Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.
9/2015	Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miwako Kobayashi Research Topics

Disease

17	COVID-19 02/2022 - 01/2021
5	Pneumococcal Infections 01/2022 - 09/2015
3	Pneumonia (Pneumonitis) 11/2019 - 01/2017
2	Diphtheria 02/2021 - 01/2021
2	Tetanus 02/2021 - 01/2021
2	Infections 01/2020 - 09/2016
2	Neoplasms (Cancer) 10/2018 - 04/2015
2	Werner Syndrome (Werner's Syndrome) 10/2018 - 04/2015
1	Disease Progression 11/2021
1	Human Influenza (Influenza) 01/2021
1	Hepatitis B 01/2021
1	Herpes Zoster 01/2021
1	Hepatitis A (Hepatitis, Infectious) 01/2021
1	Whooping Cough (Pertussis) 01/2021
1	Pneumococcal Pneumonia 11/2020
1	Meningitis 01/2020
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2020
1	Infant Death 11/2019
1	Stillbirth 11/2019
1	Diarrhea 01/2019
1	Mental Disorders (Mental Disorder) 01/2018
1	Menstruation Disturbances 01/2017
1	Hyperprolactinemia 01/2017
1	Malaria 01/2017
1	Urinary Tract Infections (Urinary Tract Infection) 09/2016
1	Tuberculosis (Tuberculoses) 01/2014
1	Kasabach-Merritt Syndrome 02/2006

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 02/2022 - 01/2017
10	mRNA VaccinesIBA 02/2022 - 07/2021
5	Messenger RNA (mRNA)IBA 02/2022 - 11/2021
5	COVID-19 VaccinesIBA 02/2022 - 05/2021
5	23-valent pneumococcal capsular polysaccharide vaccineIBA 02/2021 - 09/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 09/2016
3	Conjugate VaccinesIBA 01/2022 - 01/2020
3	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 02/2021 - 09/2015
2	Immunoglobulin G (IgG)IBA 12/2021 - 09/2021
2	Nucleic AcidsIBA 11/2021 - 01/2014
2	DiamondIBA 01/2021 - 01/2021
2	10-valent pneumococcal conjugate vaccineIBA 01/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 04/2015
2	DNA HelicasesIBA 10/2018 - 04/2015
1	BNT162 VaccineIBA 11/2021
1	Pertussis VaccineIBA 02/2021
1	Herpes Zoster VaccineIBA 02/2021
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2021
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2021
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 01/2021
1	SolutionsIBA 01/2019
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018
1	ParvalbuminsIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2017
1	Antimalarials (Antimalarial Agents)IBA 01/2017
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	GuanineIBA 04/2015
1	Vincristine (Oncovin)FDA LinkGeneric 02/2006

Therapy/Procedure

1	Artificial Respiration (Mechanical Ventilation) 11/2021
1	Fluid Therapy (Oral Rehydration Therapy) 01/2019
1	Ambulatory Care (Outpatient Care) 09/2016